Fundraising FoxBiotech Startups
11,136 companies tagged Biotech, with their investors and founders.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Veravas develops the patented VeraBIND diagnostic platform that reduces interference in laboratory testing to measure hard-to-detect biomarkers, with a current application in blood-based early detection of tau pathology associated with Alzheimer's disease. It provides tests and sample pre-treatment solutions aimed at researchers and diagnostic labs for improved assay sensitivity and biomarker detection.</parameter> <parameter name="founders">[]
0 investors
Verda Bio conducts genetic and ingredient research on cannabinoids and rare plants to develop the basis for consumer products. It focuses on producing safe, consistent, and effective plant-derived ingredients.
0 investors
0 investors
Veris Health offers the Veris Cancer Care Platform, which connects cancer patients and clinicians through symptom reporting, physiologic data from VerisBox connected devices, secure messaging, and video calls. It provides a clinician portal with EHR integration, quality-of-life assessments, and a patient app designed for value-based oncology care aligned with the Enhancing Oncology Model.
0 investors
Verismo is a biopharmaceutical company founded by the inventors of Kymriah, the first FDA-approved CAR T cell therapy, developing next-generation CAR T therapies using KIR receptor technology to address limitations in first-generation approaches.
0 investors
Verndari develops the VaxiPatch, a single-dose vaccination kit that uses intradermal microarray technology for vaccine delivery. The company focuses on vaccine delivery methods designed to be pain-free and thermostable, with pre-clinical studies indicating higher efficacy than traditional delivery.
0 investors
0 investors
0 investors
Verseon uses quantum physics-based modeling combined with AI to design novel small-molecule drug candidates for major human diseases. Its pipeline targets conditions including cardiovascular disease (anticoagulants), diabetic vision loss, multidrug-resistant cancers, and solid-tumor metastasis, with candidates ranging from preclinical to clinical stages.
0 investors
Verthermia develops HEATT (Hyperthermic Extracorporeal Applied Tumor Therapy), a whole-body hyperthermia treatment that heats a patient's blood in an external circuit to raise body temperature and target cancer cells, combined with dialysis to rebalance body chemistry. The therapy is used to treat cancers and other diseases and is administered in a hospital operating room setting.
0 investors
Vesica Health develops AssureMDx, a noninvasive urine-based genomic test that analyzes DNA methylation and somatic mutation biomarkers to assess bladder cancer risk in patients presenting with hematuria. The test helps primary care physicians and urologists triage patients for referral, avoid unnecessary invasive procedures, and support early detection of bladder cancer.
0 investors
0 investors
Vesicor develops precision-engineered cellular microvesicles that deliver p53 mRNA to cancer cells using a non-viral, immune-silent platform, aiming to restore tumor suppression in advanced solid tumors. Its lead candidate, ecm-RV/p53, and broader platform are designed for oncology therapeutics and multiple payload types.
0 investors
VesselOn is a drug development company using a platform to create enhanced versions of monoclonal antibodies, small molecules, cytokines, proteins, and other therapeutic conjugates, with initial focus on improving anti-PD-1 cancer drugs such as Keytruda. It works in the biopharmaceutical and oncology space to produce proprietary drug candidates.
0 investors
0 investors
VETmAb BIO is a veterinary biotechnology company developing monoclonal antibody (mAb) therapeutics for dogs and cats. It targets veterinarians treating companion animals, and its founding team previously built and sold KindredBio.
0 investors